Construction of recombinant bacteria and method for preparing prednisone acetate from recombinant bacteria
By constructing recombinant bacteria, using SUMO-KsdD5 fusion protein and intracellular FAD coenzyme regeneration system, combining feed culture medium and isopropanol cosolvent, the preparation process of prednisone acetate was optimized, and the substrate feeding volume in the prior art was solved. The problems of low, large enzyme dosage and long conversion time have achieved efficient conversion of prednisone acetate and improved enzyme activity.
Patent Information
- Application Number
- CN202411139079.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-08
AI Technical Summary
In the prior art, the substrate feed amount is low, the enzyme amount is large, and the conversion time is long, and high efficiency methods are lacking.
By constructing recombinant bacteria, the fusion expression of SUMO protein and KsdD5 protease is used to combine with the FAD coenzyme regeneration system in the cells to improve the solubility and expression of 3-sterone-Δ1-dehydrogenase, and use supplements in high-density fermentation Medium and isopropanol cosolvent to optimize the conversion conditions of prednisone acetate.
High-efficiency prednisone acetate preparation with high substrate feed volume, low enzyme dosage, and short conversion time is achieved, with a conversion rate of up to 96.3%, and the activity and catalytic ability of the enzyme are improved.
Smart Images

Figure CN118910113A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of microbial pharmacy and pharmaceutical chemical engineering, and in particular to the construction of a recombinant bacterium and a method for preparing prednisone acetate therefrom. Background Art
[0002] Steroid drugs refer to drugs with typical steroid structures in their molecular structures, mainly including three categories: adrenal cortical hormones, sex hormones and anabolic hormones. As the second type of drug in clinical use after antibiotics, the global annual production has exceeded 1 million tons. Microbial transformation of steroid compounds refers to the use of microbial cells or enzymes in their bodies to selectively modify or transform a specific part (group) of steroid compounds, thereby obtaining compounds or intermediates with similar structures but improved physiological activity.
[0003] Prednisolone acetate (molecular formula C 23 H 28 O6, chemical name: 17α, 21-dihydroxypregnane-1,4-diene-3,11,20-trione-21-acetate) is an important class of adrenocortical hormone drugs, which has the effects of affecting sugar metabolism, anti-inflammatory, anti-allergic, and anti-toxicity. The main production process is: first fermentation culture of bacteria containing recombinant KsdD5 enzyme, then use cortisone acetate as substrate, add bacteria obtained by fermentation centrifugation and use intracellular coenzyme FAD as electron acceptor, and additionally add PMS as an electron transport chain component to dehydrogenate C1 and C2 to obtain prednisone acetate. The technical route is as follows:
[0004]
[0005] The invention patent with patent number CN114807286A discloses a method for refining prednisone acetate based on resting cell transformation. This method uses resting cells to prepare prednisone acetate, but the substrate input amount is low, only 20-40 g / L, and the transformation time is long, requiring 2 to 3 days. Therefore, a high-efficiency method with high substrate input amount, low enzyme dosage and short transformation time is needed. Summary of the invention
[0006] In view of this, the present invention proposes a method for preparing prednisone acetate by constructing a recombinant bacterium with high substrate feeding amount, low enzyme dosage and short conversion time.
[0007] The technical solution of the present invention is implemented as follows: On the one hand, the present invention provides a method for constructing a recombinant bacterium, comprising the following steps:
[0008] S1, amplify the SUMO protein gene and KsdD5 protease gene, then cut the pET28a plasmid and seamlessly connect it with the SUMO gene and KsdD5 gene to obtain the recombinant plasmid pET28a-SUMO-KsdD5;
[0009] S2, transform the recombinant plasmid pET28a-SUMO-KsdD5 into Escherichia coli BL21 competent cells, and obtain recombinant bacteria after cultivation.
[0010] The present invention connects SUMO gene and KsdD5 to pET28a(+) plasmid to obtain recombinant dehydrogenase plasmid, and then performs fusion expression, and can utilize the FAD coenzyme regeneration system of the cell itself, without adding exogenous coenzyme FAD; in addition, SUMO protein improves the solubility of 3-sterol-Δ1-dehydrogenase in Escherichia coli BL21(DE3) and the protein expression amount of 3-sterol-Δ1-dehydrogenase in Escherichia coli BL21(DE3), and also improves the efficiency of 3-sterol-Δ1-dehydrogenase KsdD5 in converting prednisone acetate.
[0011] On the other hand, the present invention also provides a recombinant bacterium, which is constructed by the above method, and the amino acid sequence of the SUMO-KsdD5 fusion protein encoded in the recombinant plasmid pET28a-SUMO-KsdD5 is shown in SEQ ID NO.1.
[0012] In another aspect, the present invention further provides a use of a recombinant bacterium in preparing prednisone acetate, comprising the following steps:
[0013] S21, the recombinant bacteria are fermented and centrifuged to obtain a recombinant bacterial slurry;
[0014] S22, after emulsifying cortisone acetate, add isopropyl alcohol, PMS and the recombinant bacterial slurry of step S21, and transform for 24 hours to obtain prednisolone acetate.
[0015] On the basis of the above technical solution, preferably, the mass ratio of cortisone acetate to recombinant bacterial sludge is 1-4:1.
[0016] On the basis of the above technical solution, preferably, the conversion reaction conditions in step S22 are: temperature 30°C, rotation speed 200-400r / min, ventilation volume 0.3-0.8vvm, and pressure 0.01-0.05MPa.
[0017] On the basis of the above technical scheme, preferably, the fermentation and culturing method of the recombinant bacteria in step S21 is: after the secondary culture of the recombinant bacteria, inoculate them into a fermentation medium containing kanamycin, and ferment and culture them at 35°C-37°C, a rotation speed of 600-800r / min, and a ventilation volume of 2-3vvm. When the pH drops to the lowest value and begins to rebound by 8%-12%, start adding feed culture medium, and culture to the OD600 value of the bacterial liquid of 20-25, add 0.4-0.5mM IPTG to induce expression for 16-18h and then centrifuge to obtain recombinant bacterial slurry.
[0018] Based on the above technical scheme, preferably, the components of the fermentation medium are: the components of the fermentation medium are: glycerol 4-6 g / L, yeast extract powder 20-28 g / L, trypsin 15-20 g / L, kanamycin 45-55 μg / mL, potassium dihydrogen phosphate 1-3 g / L, dipotassium hydrogen phosphate 15-18 g / L and defoamer A2010.1v%-0.3v%.
[0019] On the basis of the above technical solution, preferably, the components of the feed medium are 55v%-65v% glycerol and 4-6g / L diammonium hydrogen phosphate.
[0020] During the high-density fermentation of recombinant bacteria, as the cells proliferate, the nutrients in the fermentation medium are gradually consumed. Feed medium can replenish the consumed nutrients in time in the later stage of cell growth, which helps to prolong the growth stage of cells and keep them in a highly active state. Reasonable feed can also regulate the metabolic pathways in cells, promote the synthesis of more precursor substances, and enhance the production of target metabolites.
[0021] Components in the feed medium, such as glycerol and diamine phosphate, provide cells with additional carbon and nitrogen sources, which can enhance the metabolic activity of cells. This increased metabolic activity is very important for the subsequent target protein expression, enzymatic reaction and substrate conversion efficiency. Better nutrient supply can increase the enzyme activity of cells, ensure that in the enzymatic reaction of resting cells, cells can efficiently catalyze the synthesis of target products and improve the conversion rate of prednisone acetate.
[0022] On the basis of the above technical solution, preferably, in step S22, a cosolvent is added when emulsifying cortisone acetate, and the emulsified cortisone acetate is obtained by homogenizing at 8000-12000 r / min for 10-15 min, and the particle size of the particles is less than 90 μm.
[0023] On the basis of the above technical solution, preferably, the co-solvent is isopropanol, and the concentration of isopropanol is 5v%-10v%.
[0024] When cortisone acetate is emulsified, adding isopropanol as a cosolvent can increase the solubility of cortisone acetate in water, reduce the interfacial tension during the emulsification process, and improve the emulsification effect, which allows a larger contact area to be formed between cortisone acetate and the recombinant bacteria, thus promoting the reaction. During the biotransformation process, the interaction between the enzyme and the substrate is affected by the solvent environment, and isopropanol improves the activity or stability of the enzyme to a certain extent, enhances the catalytic ability of the recombinant bacteria, and thus increases the conversion rate of the final product, prednisone acetate.
[0025] The construction of a recombinant bacterium and the method for preparing prednisone acetate of the present invention have the following beneficial effects compared with the prior art:
[0026] (1) The recombinant bacteria constructed by the present invention can utilize the FAD coenzyme regeneration system of the cell itself when transforming prednisone acetate. The reaction system does not need to add exogenous coenzyme FAD, and the efficiency of transforming prednisone acetate is also improved.
[0027] (2) During high-density fermentation, feed culture medium is added, which can not only improve the metabolic activity of cells and avoid inhibition caused by nutrient deficiency, but also increase the final conversion rate.
[0028] (3) Isopropanol as a cosolvent can increase the solubility of cortisone acetate in water, improve the emulsification effect of cortisone acetate, and promote the reaction. In addition, isopropanol enhances the catalytic ability of the recombinant bacteria to a certain extent and improves the conversion rate of prednisolone acetate. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0030] Figure 1 This is a HPLC chart of the recombinant bacteria in Example 1 of the present invention transforming prednisone acetate. DETAILED DESCRIPTION
[0031] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0032] The culture medium used in the present invention is self-prepared, and the culture medium formula is as follows:
[0033] The components of the solid culture medium are: yeast extract powder 5g / L, tryptone 10g / L, sodium chloride 10g / L, and agar powder 20g / L.
[0034] The components of the liquid culture medium in the primary and secondary seed cultures are: 5 g / L yeast extract, 10 g / L tryptone, and 10 g / L sodium chloride.
[0035] Example 1
[0036] The preparation method of prednisone acetate of the present embodiment comprises the following steps:
[0037] S1. Construction of recombinant 3-sterol-Δ1-dehydrogenase Escherichia coli (recombinant bacteria): homologous recombination primers were designed, SUMO protein gene and KsdD5 gene were amplified by PCR, and then the pET28a plasmid was double-digested with BamHI and XhoI restriction endonucleases, and the obtained SUMO gene, KsdD5 gene and the double-digested pET28a plasmid were seamlessly connected to construct the recombinant plasmid pET28a-SUMO-KsdD5. The amino acid sequence of the SUMO-KsdD5 fusion protein encoded in the recombinant plasmid pET28a-SUMO-KsdD5 is shown in SEQ ID NO.1.
[0038] Take out the BL21(DE3) competent cells from the -80℃ refrigerator, transfer the recombinant plasmid pET28a-SUMO-KsdD5 into BL21(DE3), mix and incubate to facilitate the combination of plasmid DNA and cells. After the cells are revived, evenly spread them on the solid culture medium and cultured in a 37℃ incubator for 14h to obtain recombinant 3-sterol-Δ1-dehydrogenase Escherichia coli (recombinant bacteria).
[0039] S2, high-density culture of recombinant bacteria, including seed culture and fed-batch fermentation:
[0040] S21, preparation of primary seeds of recombinant bacteria: pick a single colony of recombinant bacteria, inoculate it into LB (Luria-Bertani) liquid culture medium containing 50ug / mL kanamycin, and culture it in a constant temperature shaking incubator at 37°C and 240r / min for 12h to obtain the primary seed solution of recombinant bacteria.
[0041] S22, preparation of secondary seeds of recombinant bacteria: inoculate the prepared primary seeds of recombinant bacteria into LB liquid culture medium containing 50ug / mL of kanamycin at a ratio of 5% (v / v), and culture in a constant temperature shaking incubator at 37°C and 240r / min for 6h to obtain secondary seed solution of recombinant bacteria.
[0042] S23, high-density fermentation of recombinant bacteria: The prepared recombinant bacteria secondary seeds were inoculated into a fermentation medium containing 50ug / mL kanamycin at a ratio of 5% (v / v), and the temperature was controlled at 35°C, the rotation speed was 600r / min, and the ventilation volume was 2vvm. When the pH dropped to the minimum value and rebounded to 10%, the feed medium was added. When the OD600 value was 25, the temperature was lowered to 20°C in a stepwise manner, and IPTG with a final concentration of 0.42mol / L was added to induce the bacteria to express protein. The fermentation was terminated after induced expression for 17h, and the recombinant bacteria mud was obtained after centrifugation.
[0043] The components of the fermentation medium are: 5 g / L glycerol, 24 g / L yeast extract powder, 18 g / L tryptone, 50 μg / mL kanamycin, 2.3 g / L potassium dihydrogen phosphate, 16 g / L potassium hydrogen phosphate and 10.1 v% defoaming agent A20, sterilized at 121°C for 30 min under high temperature and high pressure.
[0044] The components of the feed medium are 60v% glycerol and 5g / L diammonium hydrogen phosphate, and are sterilized at 121°C for 30min under high temperature and high pressure.
[0045] S3, pretreatment of cortisone acetate substrate: weigh 40 g / L of cortisone acetate, add 50 mmol / L pH 7.0 Tris-HCl buffer and 5% (v / v) isopropanol, and emulsify the substrate into tiny particles (<90 μm) using a high-speed homogenizer at 8000 r / min for 15 min.
[0046] S4, prednisolone acetate resting cell enzymatic reaction conversion: add emulsified substrate to the enzyme conversion tank, add 40g / L recombinant bacterial sludge, add 0.04g / L PMS, and convert for 24h at 30℃, 200r / min, ventilation volume 0.3vvm, and tank pressure 0.05MPa.
[0047] Example 2
[0048] The preparation method of prednisone acetate of the present embodiment comprises the following steps:
[0049] S1, construction of recombinant 3-sterol-Δ1-dehydrogenase Escherichia coli (recombinant bacteria): same as Example 1.
[0050] S2, high-density culture of recombinant bacteria, including seed culture and fed-batch fermentation:
[0051] S21, preparation of primary seeds of recombinant bacteria: same as in Example 1.
[0052] S22, preparation of secondary seeds of recombinant bacteria: same as in Example 1.
[0053] S23, high-density fermentation of recombinant bacteria: The prepared recombinant bacteria secondary seeds were inoculated into a fermentation medium containing 45ug / mL kanamycin at a ratio of 10% (v / v), and the temperature was controlled at 37°C, the rotation speed was 700r / min, and the ventilation volume was 2vvm. When the pH dropped to the minimum value and rebounded to 8%, the feed medium was added. When the OD600 value was 23, the temperature was lowered to 20°C in a stepwise manner, and IPTG with a final concentration of 0.4mol / L was added to induce the bacteria to express protein. The expression was induced for 16h to end the fermentation, and the recombinant bacteria mud was obtained after centrifugation.
[0054] The components of the fermentation medium are: glycerol 4g / L, yeast extract powder 28g / L, tryptone 15g / L, kanamycin 45μg / mL, potassium dihydrogen phosphate 1g / L, dipotassium hydrogen phosphate 18g / L and defoaming agent A2010.2v%, sterilized at 121°C for 30min under high temperature and high pressure.
[0055] The components of the feed medium are 55v% glycerol and 6g / L diammonium hydrogen phosphate, and are sterilized at 121°C for 30min under high temperature and high pressure.
[0056] S3, pretreatment of cortisone acetate substrate: weigh 30 g / L of cortisone acetate, add 50 mmol / L pH 7.0 Tris-HCl buffer and 8% (v / v) isopropanol, and use a high-speed homogenizer to emulsify for 13 minutes at 10000 r / min to emulsify the substrate into tiny particles (<90 μm).
[0057] S4, prednisolone acetate resting cell enzymatic reaction conversion: add emulsified substrate to the enzyme conversion tank, add 10g / L recombinant bacterial sludge, add 0.05g / L PMS, and convert for 24h at 30℃, 400r / min, ventilation volume 0.5vvm, and tank pressure 0.03MPa.
[0058] Example 3
[0059] The preparation method of prednisone acetate of the present embodiment comprises the following steps:
[0060] S1, construction of recombinant 3-sterol-Δ1-dehydrogenase Escherichia coli (recombinant bacteria): same as Example 1.
[0061] S2, high-density culture of recombinant bacteria, including seed culture and fed-batch fermentation:
[0062] S21, preparation of primary seeds of recombinant bacteria: same as in Example 1.
[0063] S22, preparation of secondary seeds of recombinant bacteria: same as in Example 1.
[0064] S23, high-density fermentation of recombinant bacteria: The prepared recombinant bacteria secondary seeds were inoculated into a fermentation medium containing 55ug / mL kanamycin at a ratio of 8% (v / v), and the temperature was controlled at 36°C, the rotation speed was 800r / min, and the ventilation volume was 2vvm. When the pH dropped to the minimum value and rebounded to 12%, the feed medium was added. When the OD600 value was 25, the temperature was lowered to 20°C in a stepwise manner, and IPTG with a final concentration of 0.5mol / L was added to induce the bacteria to express protein. The expression was induced for 18h to end the fermentation, and the recombinant bacteria mud was obtained after centrifugation.
[0065] The components of the fermentation medium are: 6 g / L glycerol, 20 g / L yeast extract powder, 20 g / L tryptone, 55 μg / mL kanamycin, 3 g / L potassium dihydrogen phosphate, 15 g / L potassium hydrogen phosphate and 10.3 v % of defoaming agent A20, sterilized at 121° C. for 30 min under high temperature and high pressure.
[0066] The components of the feed medium are 65v% glycerol and 4g / L diammonium hydrogen phosphate, and are sterilized at 121°C for 30min under high temperature and high pressure.
[0067] S3, pretreatment of cortisone acetate substrate: weigh 20 g / L of cortisone acetate, add 50 mmol / L pH 7.0 Tris-HCl buffer and 10% (v / v) isopropanol, and use a high-speed homogenizer to emulsify the substrate into tiny particles (<90 μm) at 12000 r / min for 10 min.
[0068] S4, prednisolone acetate resting cell enzymatic reaction conversion: add emulsified substrate to the enzyme conversion tank, add 10g / L recombinant bacterial sludge, add 0.06g / L PMS, and convert for 24h at 30℃, 300r / min, ventilation volume 0.8vvm, and tank pressure 0.01MPa.
[0069] Example 4
[0070] The difference between Example 4 and Example 1 is that the amount of substrate added in step S3 is 40 g / L of cortisone acetate, the weight of the recombinant bacterial sludge in step S4 is 20 g / L, and the rest of the contents are the same.
[0071] Example 5
[0072] The difference between Example 5 and Example 1 is that the amount of substrate added in step S3 is 40 g / L of cortisone acetate, the weight of the recombinant bacterial sludge in step S4 is 10 g / L, and the rest of the contents are the same.
[0073] Example 6
[0074] The difference between Example 6 and Example 1 is that the amount of substrate added in step S3 is 50 g / L of cortisone acetate, the weight of the recombinant bacterial sludge in step S4 is 50 g / L, the amount of PMS is 0.05 g / L, and the rest of the contents are the same.
[0075] Example 7
[0076] The difference between Example 7 and Example 1 is that the amount of substrate added in step S3 is 50 g / L of cortisone acetate, the weight of the recombinant bacterial sludge in step S4 is 25 g / L, the amount of PMS is 0.05 g / L, and the rest of the contents are the same.
[0077] Example 8
[0078] The difference between Example 8 and Example 1 is that the amount of substrate added in step S3 is 50 g / L of cortisone acetate, the weight of the recombinant bacterial sludge in step S4 is 12.5 g / L, the amount of PMS is 0.05 g / L, and the rest of the contents are the same.
[0079] Example 9
[0080] The difference between Example 9 and Example 1 is that the amount of substrate added in step S3 is 60 g / L of cortisone acetate, the weight of the recombinant bacterial sludge in step S4 is 60 g / L, the amount of PMS is 0.06 g / L, and the rest of the contents are the same.
[0081] Example 10
[0082] The difference between Example 10 and Example 1 is that the amount of substrate added in step S3 is 60 g / L of cortisone acetate, the weight of the recombinant bacterial sludge in step S4 is 30 g / L, the amount of PMS is 0.06 g / L, and the rest of the contents are the same.
[0083] Embodiment 11
[0084] The difference between Example 11 and Example 1 is that the amount of substrate added in step S3 is 60 g / L of cortisone acetate, the weight of the recombinant bacterial sludge in step S4 is 15 g / L, the amount of PMS is 0.06 g / L, and the rest of the contents are the same.
[0085] Comparative Example 1
[0086] The difference between Comparative Example 1 and Example 1 is that in step S3, isopropanol is not added during the pretreatment of the cortisone acetate substrate, and the rest of the contents are the same.
[0087] Comparative Example 2
[0088] The difference between Comparative Example 2 and Example 1 is that in step S23, no feed medium is added during the high-density fermentation of the recombinant bacteria, and the rest of the contents are the same.
[0089] Comparative Example 3
[0090] The difference between Comparative Example 3 and Example 1 is that 3-sterol-Δ1-dehydrogenase is directly used to convert the cortisone acetate substrate without fusing with SUMO protein.
[0091] Preparation of prednisone acetate: The conversion liquid obtained in the example is filtered to obtain a prednisone acetate filter cake. 10 times the volume (v / v) of methanol is added to the prednisone acetate filter cake, and refluxed and stirred at 45°C for 3h to dissolve. Filter to obtain a methanol solution, add 6g of activated carbon and reflux and stir for 1h to decolorize. Filter to obtain the decolorized methanol solution, and remove methanol by negative pressure distillation at 45°C to obtain a crude prednisone acetate. Add the obtained crude prednisone acetate to 100ml of ethyl acetate, reflux and stir at 60°C for 2h, cool to 0°C for crystallization, and filter to obtain a fine prednisone acetate. Use high performance liquid chromatography (HPLC) to detect the purity of prednisone acetate.
[0092] Conversion rate and purity measurement method of prednisone acetate: Hydrocortisone acetate and prednisone acetate were analyzed using an Agilent 1260 Infinity II HPLC system equipped with a binary pump, autosampler and refractive index detector. The chromatographic column used was Agilent Eclipse Plus C18 (250×4.6mm, 5μm, USA). The mobile phase consisted of 68% ultrapure water and 32% acetonitrile with a flow rate of 1.0mL / min. The chromatographic column and detector were maintained at 30°C. The retention times of cortisone acetate and prednisone acetate were 17.0min and 15.5min, respectively. The results of quantitative analysis of prednisone acetate using the area normalization method are shown in Tables 1 and Figure 1 .
[0093] Table 1 Conversion rate, recovery rate and purity of prednisone acetate preparation
[0094]
[0095]
[0096] As shown in Table 1, when the recombinant bacteria constructed in the present invention are used to prepare prednisone acetate, the amount of bacterial sludge used can be as low as 1 / 4 of that of cortisone acetate (see Examples 5, 8, and 11), and the conversion rate in 24 hours can reach 96.3%.
[0097] For common strains (see comparative example 3), when the amount of bacterial mud used is equal to that of cortisone acetate, the 24h conversion rate is only 58.6%, which proves that the method of the present invention for converting refined prednisone acetate by resting cells has the advantages of low dosage and high conversion efficiency.
[0098] Comparative Example 1 shows that the addition of isopropanol as a cosolvent during the pretreatment of the cortisone acetate substrate increases the contact area between the cortisone acetate and the recombinant bacteria, thereby promoting the reaction. On the other hand, it improves the activity or stability of the enzyme to a certain extent, enhances the catalytic ability of the recombinant bacteria, and thus increases the conversion rate of the final product, prednisone acetate.
[0099] Comparative Example 2 shows that, in the high-density fermentation process, the final conversion rate of prednisolone acetate can be increased by reasonably adding feed culture medium and improving the metabolic activity of cells.
[0100] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for constructing a recombinant bacterium, Features: The following steps are involved: S1, amplify the SUMO protein gene and KsdD5 protease gene, then cut the pET28a plasmid and seamlessly connect it with the SUMO gene and KsdD5 gene to obtain the recombinant plasmid pET28a-SUMO-KsdD5; S2, transform the recombinant plasmid pET28a-SUMO-KsdD5 into Escherichia coli BL21 competent cells, and obtain recombinant bacteria after cultivation.
2. The recombinant bacteria obtained by the method of claim 1, Features: The amino acid sequence of the SUMO-KsdD5 fusion protein encoded in the recombinant plasmid pET28a-SUMO-KsdD5 is shown in SEQ ID NO.
1.
3. Use of the recombinant bacteria according to claim 2 in the preparation of prednisone acetate, Features: The following steps are involved: S21, the recombinant bacteria are fermented and centrifuged to obtain a recombinant bacterial slurry; S22, after emulsifying cortisone acetate, add isopropyl alcohol, PMS and the recombinant bacterial slurry of step S21, and transform for 24 hours to obtain prednisolone acetate.
4. The use according to claim 3, Features: The mass ratio of the cortisone acetate to the recombinant bacterial sludge is 1-4:
1.
5. The use according to claim 3, Features: The conversion reaction conditions in step S22 are: temperature 30° C., rotation speed 200-400 r / min, ventilation volume 0.3-0.8 vvm, and pressure 0.01-0.05 MPa.
6. The use according to claim 3, Features: The fermentation culture method of the recombinant bacteria in step S21 is as follows: after the secondary culture of the recombinant bacteria, the recombinant bacteria are inoculated into a fermentation medium containing kanamycin, and fermented and cultured at 35°C-37°C, a rotation speed of 600-800r / min, and a ventilation volume of 2-3vvm. When the pH drops to the lowest value and begins to rebound by 8%-12%, feed culture medium is added. When the OD600 value of the bacterial liquid is 20-25, 0.4-0.5mM IPTG is added to induce expression for 16-18h and then centrifuged to obtain recombinant bacterial slurry.
7. The use according to claim 6, Features: The components of the fermentation medium are: 4-6 g / L glycerol, 20-28 g / L yeast extract, 15-20 g / L tryptone, 45-55 μg / mL kanamycin, 1-3 g / L potassium dihydrogen phosphate, 15-18 g / L potassium hydrogen phosphate and 0.1 v%-0.3 v% of defoaming agent A201.
8. The use according to claim 6, Features: The components of the feed medium are 55v%-65v% glycerol and 4-6g / L diammonium hydrogen phosphate.
9. The use according to claim 3, Features: In step S22, a cosolvent is added during the emulsification of cortisone acetate, and the emulsified cortisone acetate is homogenized at 8000-12000 r / min for 10-15 min to obtain the emulsified cortisone acetate, with a particle size of less than 90 μm.
10. The use according to claim 9, Features: The auxiliary solvent is isopropanol, and the concentration of isopropanol is 5v%-10v%.
Citation Information
Patent Citations
Method for refining prednisone acetate based on resting cell transformation
CN114807286A
Cited By
Method for measuring prednisone acetate related substances by HPLC (high performance liquid chromatography) gradient elution
CN119534709A
